Synthetic nanoparticles with surface bioconjugation are promising platforms for targeted
therapy, but their simple biological functionalization is still a challenging task against the …

The fast progress in nanomedicine and nanoparticles (NP) materials presents
unconventional solutions which are expected to revolutionise health care with great …

Over the past two decades, multidisciplinary investigations into the development of
nanoparticles for medical applications have continually increased. However, nanoparticles …

Owing to the inherent shortcomings of traditional therapeutic drugs in terms of inadequate
therapeutic efficacy and toxicity in clinical treatment, nanomedicine designs have received …

Cell therapies are emerging as a promising new therapeutic modality in medicine,
generating effective treatments for previously incurable diseases. Clinical success of cell …

As a natural product with various biological activities, triptolide (TP) has been reported in
anti-inflammatory, anti-tumor and anti-autoimmune studies. However, the narrow therapeutic …

The first publication of micro‐and nanotechnology in medicine was in 1798 with the use of
the Cowpox virus by Edward Jenner as an attenuated vaccine against Smallpox. Since then …

Cancer immunotherapy is a therapeutic strategy to inhibit tumor growth and metastasis by
intervening in the immune response process. Strategies applied to cancer immunotherapy …

Vaccines represent one of the most significant advancements in public health since they
prevented morbidity and mortality in millions of people every year. Conventionally, vaccine …

Biodegradable polymers have been used as carriers in drug delivery systems for more than
four decades. Early work used crude natural materials for particle fabrication, whereas more …